Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials.

Banach M, Nikfar S, Rahimi R, Bielecka-Dabrowa A, Pencina MJ, Mikhailidis DP, Narkiewicz K, Rysz J, Ray KK, Abdollahi M; Lipid and Blood Pressure Meta-Analysis Collaboration Group.

Int J Cardiol. 2013 Oct 3;168(3):2816-24. doi: 10.1016/j.ijcard.2013.03.068. Epub 2013 Apr 18.

PMID:
23602289
2.

Antihypertensive effects of statins: a meta-analysis of prospective controlled studies.

Briasoulis A, Agarwal V, Valachis A, Messerli FH.

J Clin Hypertens (Greenwich). 2013 May;15(5):310-20. doi: 10.1111/jch.12081. Epub 2013 Mar 7.

3.

Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials.

Strazzullo P, Kerry SM, Barbato A, Versiero M, D'Elia L, Cappuccio FP.

Hypertension. 2007 Apr;49(4):792-8. Epub 2007 Feb 19.

4.

Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial.

Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH.

Arch Intern Med. 2008 Apr 14;168(7):721-7. doi: 10.1001/archinte.168.7.721.

5.
6.

A meta-analysis of randomized trials of telmisartan vs. valsartan therapy for blood pressure reduction.

Takagi H, Niwa M, Mizuno Y, Goto SN, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group.

Hypertens Res. 2013 Jul;36(7):627-33. doi: 10.1038/hr.2012.233. Epub 2013 Jan 24.

PMID:
23344134
7.

Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).

Li JJ, Lu ZL, Kou WR, Chen Z, Wu YF, Yu XH, Zhao YC; Chinese Coronary Secondary Prevention Study (CCSPS) Group.

Clin Exp Hypertens. 2010;32(8):491-8. doi: 10.3109/10641961003686427.

PMID:
21091365
8.

A meta-analysis of randomized controlled trials of azilsartan therapy for blood pressure reduction.

Takagi H, Mizuno Y, Niwa M, Goto SN, Umemoto T.

Hypertens Res. 2014 May;37(5):432-7. doi: 10.1038/hr.2013.142. Epub 2013 Oct 10.

PMID:
24108238
9.

Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis.

Messerli FH, Pinto L, Tang SS, Thakker KM, Cappelleri JC, Sichrovsky T, Dubois RW.

Am J Cardiol. 2008 Feb 1;101(3):319-25. doi: 10.1016/j.amjcard.2007.08.033.

PMID:
18237593
10.

A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?

Nikolic D, Banach M, Nikfar S, Salari P, Mikhailidis DP, Toth PP, Abdollahi M, Ray KK, Pencina MJ, Malyszko J, Rysz J, Rizzo M; Lipid and Blood Pressure Meta-Analysis Collaboration Group.

Int J Cardiol. 2013 Oct 15;168(6):5437-47. doi: 10.1016/j.ijcard.2013.08.060. Epub 2013 Aug 28.

PMID:
24016544
11.

Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients.

Kanbay M, Yildirir A, Bozbas H, Ulus T, Bilgi M, Muderrisoglu H, Akcay A, Ozdemir FN.

Ren Fail. 2005;27(3):297-303.

PMID:
15957546
12.

Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis.

Reinhart KM, Coleman CI, Teevan C, Vachhani P, White CM.

Ann Pharmacother. 2008 Dec;42(12):1766-71. doi: 10.1345/aph.1L319. Epub 2008 Nov 18.

PMID:
19017826
13.

Role and significance of statins in the treatment of hypertensive patients.

Stepien M, Banach M, Mikhailidis DP, Gluba A, Kjeldsen SE, Rysz J.

Curr Med Res Opin. 2009 Aug;25(8):1995-2005. doi: 10.1185/03007990903098081. Review.

PMID:
19555312
14.

Blood pressure-lowering effects of extended-release niacin alone and extended-release niacin/laropiprant combination: a post hoc analysis of a 24-week, placebo-controlled trial in dyslipidemic patients.

Bays HE, Maccubbin D, Meehan AG, Kuznetsova O, Mitchel YB, Paolini JF.

Clin Ther. 2009 Jan;31(1):115-22. doi: 10.1016/j.clinthera.2009.01.010.

PMID:
19243712
15.

Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.

Wang B, Zhong J, Lin H, Zhao Z, Yan Z, He H, Ni Y, Liu D, Zhu Z.

Diabetes Obes Metab. 2013 Aug;15(8):737-49. doi: 10.1111/dom.12085. Epub 2013 Mar 20.

PMID:
23433305
16.

Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.

Williams B, Lacy PS, Cruickshank JK, Collier D, Hughes AD, Stanton A, Thom S, Thurston H; CAFE and ASCOT Investigators.

Circulation. 2009 Jan 6;119(1):53-61. doi: 10.1161/CIRCULATIONAHA.108.785915. Epub 2008 Dec 22.

17.

Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis.

Johansson K, Sundström J, Neovius K, Rössner S, Neovius M.

Obes Rev. 2010 Nov;11(11):777-91. doi: 10.1111/j.1467-789X.2009.00693.x. Review.

PMID:
20025693
18.

Effects of salt substitutes on blood pressure: a meta-analysis of randomized controlled trials.

Peng YG, Li W, Wen XX, Li Y, Hu JH, Zhao LC.

Am J Clin Nutr. 2014 Dec;100(6):1448-54. doi: 10.3945/ajcn.114.089235. Epub 2014 Oct 15.

19.

Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.

Chen JM, Heran BS, Perez MI, Wright JM.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007185. doi: 10.1002/14651858.CD007185.pub2. Review.

PMID:
20091622
20.

Isometric exercise training for blood pressure management: a systematic review and meta-analysis.

Carlson DJ, Dieberg G, Hess NC, Millar PJ, Smart NA.

Mayo Clin Proc. 2014 Mar;89(3):327-34. doi: 10.1016/j.mayocp.2013.10.030. Review.

PMID:
24582191

Supplemental Content

Support Center